Skip to Main Content

Advertisement

Skip Nav Destination

Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials?

Blood (2012) 120 (25): 4913–4920.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement